Inhalation Anesthesia Market Is Anticipated To Reach USD 1.4 Billion By 2025

Global Inhalation Anesthesia Market is anticipated to reach USD 1.4 billion by 2025. Inhalation anesthesia, as the name suggests, implies an anesthesia that could be inhaled. Moreover, increase in population coupled with increasing number of chronic diseases such as neurological, cardiovascular, cancer, and respiratory disorders and introduction and development of advanced anesthesia will drive growth of the inhalation anesthesia in the upcoming period.

The factors that propel the growth of the inhalation anesthesia market include rising investment in healthcare sector in emerging economies and growing acceptance of universal health coverage results in demand for public as well as private healthcare setups. Furthermore, increasing number of emergency surgeries driving the number of hospital admissions with public and private insurance and rising disposable income. On the other hand, there are factors that may hamper the growth of the market including recent patent expiries and generic struggle for almost all the halogenated agents. Inhalation anesthesia industry is anticipated to grow at a significant CAGR of 3.5% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Browse Full Research Report @ 
https://www.millioninsights.com/industry-reports/inhalation-anesthesia-market-size 

Inhalation anesthesia market may be explored by product type, application, and geography. The market may be explored by product type as Sevoflurane, Desflurane, Isoflurane. The “Sevoflurane” segment led the inhalation anesthesia industry in 2017 and is anticipated to maintain its dominance by 2022. The key factors that may attributed to the growth of market includes shorter wake-up time, easy maintenance and control of sedation, and lower resistance as compared to other drugs.

The key applications that could be explored in the inhalation anesthesia market include hospitals and ambulatory surgery center. The “Ambulatory Surgical Centers” segment led the inhalation anesthesia industry in 2017 and is anticipated to maintain its dominance by 2022. The key factors that may attributed to the growth of market includes increasing number of surgeries performed in these centers and growing base of ambulatory surgical centers.

North America accounted for the major market share of the inhalation anesthesia in 2017 and will continue to lead in the forecast period. The factors that could be attributed to the growth include developed healthcare infrastructure, rise in disposable income, large surgical patient pool and growing healthcare spending. North America is followed by Asia-Pacific owing to emerging healthcare infrastructure and increasing healthcare tourism in countries like India.

Some of the key players that fuel the growth of the inhalation anesthesia industry comprise Baxter; Hikma Pharmaceuticals PLC; Halocarbon Products Corporation; Piramal Enterprises Ltd.; Lunan Pharmaceutical Group Co., Ltd.; AbbVie Inc.; Jiangsu Hengrui Medicine Co. Ltd.; and Fresenius Kabi Ag. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/inhalation-anesthesia-market-size/request-sample

Market Segment:

Inhalation Anesthesia Product Outlook (Volume (000’ Units); Revenue (USD Million), 2014 – 2025)

  • Sevoflurane
  • Desflurane
  • Isoflurane

Inhalation Anesthesia Application Outlook (Volume (000’ Units); Revenue (USD Million), 2014 – 2025)

  • Induction
  • Maintenance

Inhalation Anesthesia Regional Outlook (Volume (000’ Units); Revenue (USD Million), 2014 – 2025)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • U.K.
  • France
  • Spain

Asia Pacific

  • China
  • Japan

Latin America

  • Brazil
  • Mexico
  • Middle East & Africa
  • South Africa

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/pharmaceuticals

For more details please visit @ Million Insights

Contact Details:
Company Name: Million Insights
Contact Person: Ryan Manuel
Phone: 91-20-65300184
Toll Free: 1-866-831-4085
Email:sales@millioninsights.com
Address: Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Matched content

Editor’s pick

Express Press Release Distribution
The entire EPR Network is up for sale!
This is default text for notification bar